Summary
Eighteen patients with atopic dermatitis were randomly chosen for a clinical trial to compare the action of the H2 receptor antagonist cimetidine in combination with the H1 receptor antagonist chorpheniramine against chlorpheniramine alone and against placebo. Each treatment period lasted for 4 weeks. Intensity of puritus was recorded daily by the patient on an analogue scale. Global clinical assessment was graded on a 5-point scale every 2 weeks by the investigators and weekly by the patient himself. Further study parameters were: quantity of the corticosteroid ointment used for ‘emergencies’, immunoglobulin E level, and eosinophil count. The data of 16 patients was evaluated. These was no significant difference in any of the study parameters during the three treatment periods. On the basis of this study, the combined administration of H1 and H2 receptor antagonists is of no benefit in the treatment of atopic dermatitis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Busse WW, Lantis SDH (1979) Impaired H2 histamine granulocyte response in active atopic eczema. J Invest Dermatol 73:184–187
Colin-Jones DG, Misiewicz JJ, Milton-Thomson GJ, Hunt RH, Goldin PI (1978) Cimetidine and carbenoxdone in gastric ulcer. In: Wastell C, Lance P (eds) Cimetidine — The Westminster Hospital Symposium 1978. Churchill Livingstone, London, pp 289–291
Corbett R, Greaves MW (1979) Histamine H2 receptor antagonists inhibit enzymic histamine degradation in human skin. Clin Exp Dermatcl 4:99–102
Davies MG, Greaves MW (1981) The current status of histamine receptors in human skin: therapeutic implications. Br J Dermatol 104:601–606
Davies MG, Marks R, Horton RJ, Storari FE (1979) The efficacy of histamine antagonists as antipruritics in experimentally induced pruritus. Arch Dermatol Res 266:117–120
Foulds IS, MacKie RM (1981) Adouble-blind trial of the H2 receptor antagonist cimetidine, and the H1 receptor antagonist promethazine hydrochloride in the treatment of atopic dermatitis. Clin Allergy 11:319–323
Greaves MW, Marks R, Robertson I (1977) Receptors for histamine in human skin blood vessels: A review. Br J Dermatol 97:225–228
Hägermark Ö, Strandberg K, Grönneberg R (1979) Effects of histamine receptor antagonists on histamine-induced responses in human skin. Acta Derm Venereol (Stockh) 59:297–300
Johnson HH, De Orco GA, Lascheid OP, Mitchell F (1960) Skin histamine levels in chronic atopic eczeme. J Invest Dermatol 34:237–241
Lebel B, Venencie PY, Saurat JH, Soubrane C, Paupe J (1980) Anti-IgE induced histamine release from basophils in children with atopic dermatitis. Acta Derm Venereol (Stockh) 92:57–59
Marks R, Greaves MW (1977) Vascular reactions to histamine and compound 48/80 in human skin: Suppression by a histamine H2 receptor blocking agent. Br J Clin Pharmacol 4:367–369
Matthews CNA, Boss JM, Warin RP, Storari F (1979) The effect of H1 and H2 histamine antagonists on symptomatic dermographism. Br J Dermatol 101:57–61
Ring J, Senter T, Arroyare CM, Cornelli R, Tan EM (1978) Role of complement and histamine in atopic dermatitis. Clin Res 26:210
Verhaegen H, Cook W de, Cree J (1977) Histamine receptor-bearing peripheral T lymphocytes in patients with allergies. J Allergy 59:266–268
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frosch, P.J., Schwanitz, H.J. & Macher, E. A double blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis. Arch Dermatol Res 276, 36–40 (1984). https://doi.org/10.1007/BF00412560
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00412560